Literature DB >> 29334244

Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm.

Francesca Sanguedolce1, Matteo Brunelli2, Alessandro D'amuri3, Beppe Calò4, Vito Mancini4, Giuseppe Carrieri4, Luigi Cormio4.   

Abstract

CONTEXT: The classification of flat non-neoplastic urothelial lesions has been evolved through the years in the attempt to better define a spectrum of morphologic entities with somewhat overlapping features. Differentiating these lesions is important because of differences in patient management and clinical outcome. Materials and methods and objective: A systematic review of the literature has been carried out in order to (1) assess the most striking clinical features of each lesion and (2) identify those morphological traits and immunophenotypical markers which may aid in the differential diagnosis. RESULTS AND
CONCLUSION: Our results point out the importance of a proper definition of flat non-neoplastic urothelial lesions in order to predict clinical behaviour and allow tailored patient management; therefore, we attempted to construct a novel and "easy to use" algorithm for a clear, standardized and evidence-based pathological diagnosis.

Entities:  

Keywords:  Flat lesions; bladder; immunohistochemistry

Mesh:

Substances:

Year:  2018        PMID: 29334244     DOI: 10.1080/1354750X.2018.1428360

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  3 in total

Review 1.  Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression.

Authors:  Francesca Sanguedolce; Magda Zanelli; Andrea Palicelli; Stefano Ascani; Maurizio Zizzo; Giorgia Cocco; Lars Björnebo; Anna Lantz; Ugo Giovanni Falagario; Luigi Cormio; Giuseppe Carrieri
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

2.  DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.

Authors:  Xiao-Ping Liu; Xiao-Hong Yin; Xiang-Yu Meng; Xin-Hui Yan; Yue Cao; Xian-Tao Zeng; Xing-Huan Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

3.  The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer.

Authors:  B Calò; F Sanguedolce; F Fortunato; G Stallone; N d'Altilia; M Chirico; U Falagario; Vito Mancini; G Carrieri; L Cormio
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.